Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference